Publications
Our research is regularly featured in leading scientific journals across the fields of metabolism, pharmacology, cannabinoid science, and translational medicine. These publications reflect our lab’s commitment to advancing fundamental knowledge and developing innovative therapeutic strategies with real-world impact.

5-Methoxy-2-aminoindane Reverses Diet-Induced Obesity and Improves Metabolic Parameters in Mice: A Potential New Class of Antiobesity Therapeutics
Baraghithy S, Gammal A, Permyakova A, Hamad S, Kočvarová R, Calles Y and Tam J
Appeared on the August 2024 Supplemental Cover Page of ACS Pharmacol Transl Sci

Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced Chronic Kidney Disease
Permyakova A, Hamad S, Hinden L, Baraghithy S, Kogot-Levin A, Yosef O, Shalev O, Tripathi MK, Amal H, Basu A, Arif M, Cinar R, Kunos G, Berger M, Leibowitz G, Tam J
Appeared on the March 2024 cover page of J Am Soc Nephrol
Featured in J Am Soc Nephrol 1;35(3):257-258, 2024.

Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans
Wreven E, Ruiz de Adana MS, Gmyr V, Kerr-Conte J, Vallejo Herrera MJ, Hinden L, Benavides Espínola IC, Gómez Duro M, Salido LS, Bermúdez-Silva FJ, Linares F, Tam J, Egan JM, Olveira G, Pattou F, González-Mariscal I

Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3
Szanda G, Jourdan T, Wisniewski E, Cinar R, Godlewski G, Rajki A, Liu J, Chedester L, Szalai B, Tóth AD, Soltész-Katona E, Hunyady L, Inoue A, Horváth VB, Spät A, Tam J, Kunos G
NO RESULTS
- Page 2



